Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TLV/TKUN stock hub

TLV/TKUN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/TKUNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16M

Tel Aviv Stock Exchange

Market data

Price

Recent price action with selectable time range.

TLV/TKUNTLV/TKUN

—

Loading chart…

In the news

Latest news · TLV/TKUN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-270.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/TKUN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

ILS

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	19
Employees Change	-32%
Employees Change Percent	-62.75
Enterprise value	ILA 21.9M
Exchange	Tel Aviv Stock Exchange
Financial currency	ILS
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	IL0010843675
Last refreshed	2026-05-10
Market cap	ILA 16M
Price	ILA 1,880
Price currency	ILA
Rev Per Employee	2,275,500x
Sector	Healthcare
Sic	2834
Symbol	tlv/TKUN
Website	https://www.tikun-olam.org.il

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-99.25%
EV Earnings	-1.38x
EV/EBITDA	4.85x
EV/Sales	2.41x
P/B ratio	-0.76x
P/S ratio	1.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-87.53%
EBITDA Margin	43.52%
Gross margin	19.25%
Gross Profit	ILA 1.8M
Gross Profit Growth	-61.49%
Gross Profit Growth Q	73.4%
Gross Profit Growth3 Y	-50.98%
Gross Profit Growth5 Y	-31.83%
Net Income	ILA -15.9M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-173.81%
Profit Margin	-174.17%
Profit Per Employee	ILA -4M
ROA	-39.05
Roa5y	-19.09
ROCE	41.22
ROIC	-270.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-42.03%
Cagr15y	-32.69%
Cagr1y	-51.45%
Cagr20y	-24.28%
Cagr3y	-16.07%
Cagr5y	-49.06%
Div CAGR3	62.61%
Div CAGR5	-9.03%
EPS Growth Quarters	1
EPS Growth Years	2
FCF Growth	4,317.58%
OCF Growth	218.29%
Revenue Growth	-79.02x
Revenue Growth Q	-35x
Revenue Growth Years	0x
Revenue Growth3 Y	-42.33x
Revenue Growth5 Y	-27.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.71
Assets	ILA 1.5M
Cash	ILA 30,000
Current Assets	ILA 6.5M
Current Liabilities	ILA 19.9M
Debt	ILA 13.7M
Debt EBITDA	ILA 3.04
Equity	ILA -21M
Interest Coverage	-7.09
Liabilities	ILA 22.5M
Long Term Assets	ILA -5M
Long Term Liabilities	ILA 2.5M
Net Cash	ILA -13.7M
Net Cash By Market Cap	ILA -85.89
Net Debt EBITDA	ILA 3.46
Tangible Book Value	ILA -13.2M
Tangible Book Value Per Share	ILA -15.5
WACC	7.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.06
Inventory Turnover	10.8
Net Working Capital	ILA -7.5M
Quick ratio	0.02
Working Capital	ILA -19.5M
Working Capital Turnover	ILA -1.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-41.02%
Dividend per share	ILA 0
Last Dividend	ILA 15,060

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.57%
1Y total return	-51.42%
200-day SMA	3,089.8
3Y total return	-40.88%
50-day SMA	2,044.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.57%
All Time High	18,800,000
All Time High Change	-99.99%
All Time High Date	2000-03-28
All Time Low	99.99
All Time Low Change	1,780.19%
All Time Low Date	2018-11-21
ATR	171.7
Beta	0.74
Beta1y	-1.34
Beta2y	-0.63
Ch YTD	-20.68
High	1,943
High52	4,200
High52 Date	2025-07-08
High52ch	-56.78%
Low	1,725
Low52	1,700
Low52 Date	2026-05-07
Low52ch	10.59%
Ma50ch	-8.05%
Price vs 200-day SMA	-39.16%
RSI	44.86
RSI Monthly	33.51
RSI Weekly	15.58
Sharpe ratio	-0.44x
Sortino ratio	-0.55
Total Return	-41.02%
Tr YTD	-20.68
Tr15y	-99.74%
Tr1m	-19.07%
Tr1w	-1.05%
Tr3m	-21.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -8M
Operating Income Growth Q	-68.71
Operating margin	-87.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	478,674%
Net Borrowing	-1,370,000
Shares Insiders	43.66%
Shares Out	849,645
Shares Qo Q	132.75%
Shares Yo Y	41.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	760.3x
Bv Per Share	-15.5
Ch10y	-99.67
Ch15y	-99.95
Ch1m	-19.07
Ch1w	-1.05
Ch1y	-51.42
Ch20y	-99.99
Ch3m	-21.34
Ch3y	-40.88
Ch5y	-96.81
Ch6m	-44.71
Change	8.99%
Change From Open	8.99
Close	1,725
Days Gap	0
Depreciation Amortization	11,928,000
Dollar Volume	2,165,760
Earnings Date	2026-05-29
EBIT	ILA -8M
EBITDA	ILA 4M
EPS	ILA -18.66
F Score	3
Financing CF	-2,762,000
Fiscal Year End	December
Founded	2,006
Investing CF	622,000
Is Primary Listing	1
Last Earnings Date	2025-12-01
Last Report Date	2024-12-31
Last Split Date	2026-03-02
Last Split Type	Reverse
Ma150	2,837.9
Ma150ch	-33.75%
Ma20	2,027.2
Ma20ch	-7.26%
Net CF	-130,000
Next Earnings Date	2026-05-29
Open	1,725
P OCF Ratio	7.95
Position In Range	71.1
Ppne	7,314,000
Price Date	2026-05-08
Price EBITDA	ILA 4.03
Relative Volume	1.54x
Revenue	9,102,000x
SBC By Revenue	2.23x
Share Based Comp	203,000
Tr20y	-99.62%
Tr6m	-44.71%
Volume	1,152
Z Score	-298.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/TKUN pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/TKUN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/TKUN?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+43.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+41.0%

Negative means the company is buying back shares.

Technical

TLV/TKUN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.9

Neutral momentum band

Price vs 200-day MA

-39.2%

50/200-day relationship not available

Beta (5Y)

0.74

Less volatile than the market

Sharpe ratio

-0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/TKUN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/TKUN stock rating?

tlv/TKUN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/TKUN analysis?

The full report lives at /stocks/tlv/TKUN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/TKUN?

The latest report frames tlv/TKUN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/TKUN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.